Mick Virginie, Rebollo María José, Lucía Ainhoa, García María Jesús, Martín Carlos, Aínsa José Antonio
Departamento de Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Zaragoza, C/Domingo Miral s/n, 50009 Zaragoza, Spain.
J Antimicrob Chemother. 2008 Jan;61(1):39-45. doi: 10.1093/jac/dkm440. Epub 2007 Nov 20.
To analyse the correlation between the expression levels of the aac(2')-Id gene from Mycobacterium smegmatis mc(2)155 and the resistance levels to aminoglycosides conferred by the encoded aminoglycoside 2'-N-acetyltransferase [AAC(2')-Id].
Expression levels were studied using a transductional fusion with the lacZ gene. The promoter region was characterized by primer extension analysis and ribonuclease protection assay. The aac(2')-Id gene was placed under the control of different mycobacterial promoters; deletions of the promoter region were done. Each of the plasmids was introduced in M. smegmatis mc(2)155 and the MICs were determined by resazurin assay.
The aac(2')-Id gene is transcribed from two promoters: P1 (weaker) and P2 (stronger) located 38 and 1 nt upstream of the start codon, respectively. P2 promoter (producing a leaderless mRNA) was confirmed by producing deletions in the aac(2')-Id promoter and analysing the ability of the re-constructed genes to confer resistance to aminoglycosides. The expression levels (in terms of beta-galactosidase units) varied during the phase of growth of cultures, reaching high levels during the early exponential and the stationary phase and reduced levels during entry into stationary phase. Both the levels of expression and the MICs were more elevated at lower temperatures. Cloning the gene under the control of other strong mycobacterial promoters also resulted in higher MIC values.
In M. smegmatis mc(2)155, the aminoglycoside resistance levels conferred by the AAC(2')-Id enzyme directly rely on the strength of the promoter driving transcription of the aac(2')-Id gene.
分析耻垢分枝杆菌mc(2)155的aac(2')-Id基因表达水平与由编码的氨基糖苷2'-N-乙酰基转移酶[AAC(2')-Id]赋予的对氨基糖苷类药物耐药水平之间的相关性。
利用与lacZ基因的转导融合研究表达水平。通过引物延伸分析和核糖核酸酶保护试验对启动子区域进行表征。将aac(2')-Id基因置于不同分枝杆菌启动子的控制之下;对启动子区域进行缺失操作。将每个质粒导入耻垢分枝杆菌mc(2)155,并通过刃天青试验测定最低抑菌浓度(MIC)。
aac(2')-Id基因由两个启动子转录:P1(较弱)和P2(较强),分别位于起始密码子上游38和1个核苷酸处。通过在aac(2')-Id启动子中产生缺失并分析重组基因赋予对氨基糖苷类药物耐药性的能力,证实了P2启动子(产生无 leader 的mRNA)。表达水平(以β-半乳糖苷酶单位计)在培养物生长阶段有所变化,在指数早期和稳定期达到高水平,而在进入稳定期时水平降低。在较低温度下,表达水平和MIC均更高。将该基因克隆到其他强分枝杆菌启动子的控制之下也导致更高的MIC值。
在耻垢分枝杆菌mc(2)155中,由AAC(2')-Id酶赋予的氨基糖苷类耐药水平直接依赖于驱动aac(2')-Id基因转录的启动子的强度。